RA0804

antibody from Oursmab

Targeting: TSLP

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0804

Provider

Oursmab

Product name

Tezepelumab (Biosimilar Reference Antibody) (TSLP)

Antibody type

Monoclonal

Description

Tezepelumab is a fully human monoclonal antibody targeting thymic stromal lymphopoietin (TSLP), an epithelial-derived cytokine that initiates type 2 immune responses. It binds to TSLP, preventing its interaction with the TSLP receptor complex, thereby blocking downstream inflammatory pathways. It is approved for the treatment of severe asthma, particularly in patients with uncontrolled disease regardless of eosinophil levels.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Tezepelumab (Biosimilar Reference Antibody) (TSLP)-RA0804-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Tezepelumab (Biosimilar Reference Antibody) (TSLP)-RA0804 in a linear range of 15.63¨C125 ng/mL.